Biography
Taya Bokert is an associate in Weil’s Technology & IP Transactions practice and is based in New York. Taya participates in advising Firm clients in a variety of matters relating to the licensing, acquisition, development, sale, use and commercial exploitation of intellectual property and technology. She also participates in advising clients regarding privacy and data security issues in the context of corporate transactions.
Taya has been part of the teams advising:
- Sanofi in its $9.5 billion acquisition of Blueprint Medicines
- TCV in its investment in Cloudsmith Inc.
Taya received her J.D., magna cum laude, from Fordham University School of Law where she was a Fordham Law Review Member, Pro Bono Scholar and member of the Alpha Sigma Nu Honor Society. She received her B.A., cum laude, from Washington University in St. Louis.